Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,357,975 papers from all fields of science
Search
Sign In
Create Free Account
Keratin-19
Known as:
19 keratin
, Cytokeratin-19
, Keratin 19
Expand
A type I keratin found associated with KERATIN-7 in ductal epithelia and gastrointestinal epithelia.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
15 relations
Cytokeratin 19:ACnc:Pt:Plr fld:Qn
Cytokeratin 19:MCnc:Pt:Body fld:Qn
Cytokeratin 19:MCnc:Pt:Ser/Plas:Qn
In Blood
Expand
Narrower (2)
KRT19 protein, human
antigen CYFRA21.1
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Association of Clinical Stages of Oral Submucous Fibrosis to Cytokeratin 19 Immunohistochemical Staining
B. K. Kumar
,
S. N. Malik
,
Zankana Vyas
,
H. Kotari
,
V. Prabhu
,
M. Alam
2018
Corpus ID: 52236864
Introduction: Oral submucous fibrosis (OSF) is the most common potentially malignant disorders which is widely spread and has…
Expand
2014
2014
Limbal Stem Cells in Dogs and Cats Their Identification Culture and Differentiation into Keratinocytes
I. Sancak
,
Asuman Özen
,
+4 authors
T. Delibaşı
2014
Corpus ID: 55584929
Limbal epithelial stem cells are the source of regeneration of the corneal epithelium in normal and diseased conditions and it is…
Expand
2013
2013
Disseminated tumour cells in bone marrow in experimental colon cancer: metastatic or resident?
M. Barone
,
D. Altomare
,
+5 authors
A. Leo
Colorectal Disease
2013
Corpus ID: 205025825
There are conflicting data on the biological and prognostic significance of disseminated tumour cells (DTCs) in the bone marrow…
Expand
2011
2011
THE VALUE OF CK19, KI-67 AND P53 EXPRESSION IN THE DIAGNOSIS OF THYROID FOLLICULAR NEOPLASMS
M. Cornianu
,
A. Dema
,
+5 authors
A. Faur
2011
Corpus ID: 38062585
Introduction: Cytokeratin-19 (CK19), p53 and Ki-67 are some of the proposed markers for differentiating benign from malignant…
Expand
2010
2010
Immunohistochemical Expression of Cytokeratin-19 in Non Small Cell Lung Carcinomas - An Experience from a Tertiary Care Hospital in Lahore
N. Naseem
,
N. Reyaz
,
A. Nagi
,
M. Ashraf
,
W. Sami
2010
Corpus ID: 33716089
Objective:: Previous literature reveals a significant recognition of Cytokeratin (CK) 19 as a reliable tumour marker in…
Expand
2009
2009
The Value of Cytokeratin-19 Immunohistochemistry in the Differential Diagnosis of Papillary Thyroid Carcinomas
F. Barut
,
S. Bektaş
,
B. Bahadır
,
N. Kandemır
,
N. Karadayı
,
Ş. Özdamar
2009
Corpus ID: 58812223
ABS TRACT Ob jec ti ve: The gold stan dard for di ag no sis of pa pil lary thyro id car ci no ma is con venti o nal his to logy…
Expand
2008
2008
Telomeric 3' overhangs in chronic HBV-related hepatitis and hepatocellular carcinoma
박영년
,
오봉경
,
최진섭
2008
Corpus ID: 116085997
2006
2006
Quantitative real-time RT-PCR detection for CEA , CK 20 and CK 19 mRNA in peripheral blood of colorectal cancer patients *
Xu Dong
,
Xu-fen Li
,
Zheng Shu
,
Wen-zhi Jiang
2006
Corpus ID: 16293526
This study is aimed at establishing a sensitive approach to detect disseminated tumor cells in peripheral blood and evaluate its…
Expand
2004
2004
Elevated cytokeratin-19 expression associated with apoptotic resistance and malignant progression of human cervical carcinoma
C. Yuan
,
T-S. Huang
,
H. Ng
,
R. Liu
,
M. Hung
,
L. Tsai
Apoptosis
2004
Corpus ID: 8896278
Cytokeratin-19 is an intermediate filament protein associated with the integrity of cell structure, and its elevated expression…
Expand
1996
1996
Sweat duct milia – immunohistological analysis of structure and three-dimensional reconstruction
Y. Honda
,
K. Egawa
,
Yuji Baba
,
T. Ono
Archives of Dermatological Research
1996
Corpus ID: 20944550
The fine structure of sweat duct milia and the pathomechanism in their aetiology are still unknown. To examine the relationship…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE